Advertisement

Case Studies of Cardiac Resynchronization Therapy “Nonresponders”

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Cardiac Electrophysiology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Young J.B.
        • Abraham W.T.
        • Smith A.L.
        • et al.
        Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD trial.
        JAMA. 2003; 289: 2685-2694
        • Linde C.
        • Abraham W.T.
        • Gold M.R.
        • et al.
        Randomized trial of resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.
        J Am Coll Cardiol. 2008; 52: 1834-1843
        • Moss A.J.
        • Hall W.J.
        • Cannom D.S.
        • et al.
        Cardiac-resynchronization therapy for the prevention of heart-failure events.
        N Engl J Med. 2009; 361: 1329-1338
        • Tang A.
        • Wells G.A.
        • Talajic M.
        • et al.
        Cardiac -resynchronization therapy for mild-to- moderate heart failure.
        N Engl J Med. 2010; 363: 2385-2395
        • Rickard J.
        • Michtalik H.
        • Sharma R.
        • et al.
        Predictors of response to cardiac resynchronization therapy: a systematic review.
        Int J Cardiol. 2016; 225: 345-352
        • Steffel J.
        • Ruschitzka f
        Superresponse to cardiac resynchronization therapy.
        Circulation. 2014; 130: 87-90
        • Gold M.
        • Rickard J.
        • Daubert J.C.
        • et al.
        Redefining the classification of response to cardiac resynchronization therapy: results from the REVERSE study.
        JACC Clin Electrophysiol. 2021; 7: 871-880
        • Rickard J.
        • Chang A.
        • Spragg D.D.
        • et al.
        Durability of the survival effect of cardiac resynchronization therapy by level of left ventricular functional improvement: fate of "nonresponders.
        Heart Rhythm. 2014; 11: 412-416
        • Varma N.
        • Boehmer J.
        • Bhargava K.
        • et al.
        Evaluation, management, and outcomes of patients poorly responsive to cardiac resynchronization device therapy.
        J Am Coll Cardiol. 2019; 21: 2588-2603
        • Mullens W.
        • Grimm R.A.
        • Verga T.
        • et al.
        Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program.
        J Am Coll Cardiol. 2009; 53: 765-773
        • Altman R.K.
        • Parks K.A.
        • Schlett C.L.
        • et al.
        Multidisciplinary care of patients receiving cardiac resynchronization therapy is associated with improved clinical outcomes.
        Eur Heart J. 2012; 17: 2181-2188
        • Gorodeski E.Z.
        • Magnelli-Reyes C.
        • Moennich L.A.
        • et al.
        Cardiac resynchronization therapy-heart failure (CRT-HF) clinic: a novel model of care.
        PLoS One. 2019; 14: e0222610
        • Ellenbogen K.A.
        • Gold M.R.
        • Meyer T.E.
        • et al.
        Primary results from the smartdelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography- guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy.
        Circulation. 2010; 122: 2660-2668
        • Abraham W.T.
        Frequent optimization study using the QuickOpt method.
        Am Heart J. 2010; 159: 944-948
      1. Weiss R. V-V Optimization in cardiac resynchronization therapy non-responders: RESPONSE-HF trial results. Abstract AB12-5, HRS 2010, Denver, Colorado.

        • Jones S.
        • Shun-Shin M.J.
        • Cole G.D.
        • et al.
        Applicability of the iterative technique for cardiac resynchronization therapy optimization: full-disclosure, 50-sequential-patient dataset of transmitral Doppler traces, with implications for future research design and guidelines.
        Europace. 2014; 16: 541-550
        • Sun J.P.
        • Lee A.P.
        • Grimm R.A.
        • et al.
        Optimization of atrioventricular delay during exercise improves cardiac output in patients stabilized with cardiac resynchronization therapy.
        Heart. 2012; 98: 54-59
        • Vergrugge F.H.
        • Dubont M.H.
        • Rivero-Ayerz
        • et al.
        Comorbidity significantly affects clinical outcome after cardiac resynchronization therapy regardless of ventricular remodeling.
        J Card Fail. 2012; 18: 845-853
        • Kubala M.
        • Guedon-Moreau L.
        • Snelme F.
        • et al.
        Utility of frailty assessment for elderly patients undergoing cardiac resynchronization therapy.
        JACC Clin Electrophysiol. 2017; 13: 1523-1533
        • Rickard J.
        • Brennan D.O.
        • Martin D.O.
        • et al.
        The impact of left ventricular size on response to cardiac resynchronization therapy.
        Am Heart J. 2011; 162: 646-653
        • Rickard J.
        • Patel D.
        • ParkC
        • et al.
        Long-term outcomes in patients with a left ejection fraction ≤15% undergoing cardiac resynchronization therapy.
        JACC Clin Electrophysiol. 2021; 7: 36-46
        • Dong Y.X.
        • Powell B.D.
        • Asirvatham S.J.
        • et al.
        Left ventricular lead position for cardiac resynchronization: a comprehensive cinegraphic, echocardiographic, clinical, and survival analysis.
        Europace. 2012; 14: 1139-1147
        • Singh J.P.
        • Klein H.U.
        • Huang D.T.
        • et al.
        Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial.
        Circulation. 2011; 123: 1159-1166
        • Cheng A.
        • Landman S.R.
        • Stadler R.W.
        Reasons for loss of cardiac resynchronization therapy pacing insights from 32 844 patient.
        Circ Arrythm Electrophysiol. 2012; 5: 885-888
        • Hayes D.
        • Boehmer J.P.
        • Day J.D.
        • et al.
        Cardiac resynchronization therapy and the relationship of percent biventricular pacing to survival.
        Heart Rhythm. 2011; 8: 1469-1475
        • Beshai J.F.
        • Grimm R.A.
        • Nagueh S.F.
        • et al.
        Cardiac-resynchronization therapy in heart failure with narrow QRS complexes.
        N Engl J Med. 2007; 357: 2461-2471
        • Ruschitzka F.
        • Abraham W.T.
        • Singh J.P.
        • et al.
        Cardiac-resynchronization therapy in heart failure with a narrow QRS complex.
        N Engl J Med. 2013; 369: 1395-1405
        • Van Stipdonk
        • Hoogland R.
        • Ter Horst I.
        • et al.
        Evaluating electrocardiography-based identification of cardiac resynchronization therapy responders beyond current left bundle branch block definitions.
        J Am Coll Cardiol. 2020; 6: 193-203
        • Escahlier R.
        • Ploux S.
        • Ritter P.
        • et al.
        Nonspecific intraventrciualr conduction delay: definitions, prognosis, and implictions for cardiac resynchronization therapy.
        Heart Rhythm. 2015; 12: 1071-1079
        • Strik M.
        • Ploux S.
        • Huntjens P.R.
        • et al.
        Response to cardiac resynchronization therapy is determined by intrinsic electrical substrate rather then by its modifications.
        Int J Cardiol. 2018; 270: 143-148
        • Kosmidou I.
        • Lindenfeld J.
        • Abraham W.T.
        • et al.
        Transcatheter mitral valve repair in patients with and without cardiac resynchronization therapy.
        Circ Heart Fail. 2020; 13: e007293
        • Seifert M.
        • Schau T.
        • Schoepp M.
        • et al.
        MitraClip in CRT non-responders with severe mitral regurgitation.
        Int J Cardiol. 2014; 177: 79-85
        • Chun K.-H.
        • Oh J.
        • Yu H.T.
        • et al.
        The role of sacubitril/valsartan in the management of cardiac resynchronization therapy non-responders: a retrospective analysis.
        ESC Heart Fail. 2020; 11: 4404-4407
        • Lakireddy D.
        • Di Biase L.
        • Ryschon K.
        • et al.
        Radiofrequency ablation of premature ventricular ectopy improves the efficacy of cardiac resynchronization therapy in nonresponders.
        J Am Coll Cardiol. 2012; 60: 1531-1539